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Abstract
Objective: To investigate factors associated with a woman’s willingness to pay (WTP) for injectable contraceptives in Tigray,
Ethiopia.
Methods: We used a multistage random sampling design to generate a representative sample of reproductive age women
from the Central Zone of Tigray, Ethiopia to participate in a survey (N = 1490). Respondents who had ever used injectable
contraceptives or who were interested in using them were asked whether they would be willing to pay, and if so, how
much. Logistic regression odds ratios (ORs) with 95% confidence intervals (CIs) and p-values were used to assess which
factors were associated with WTP in our final model.
Findings: On average, respondents were willing to pay 11 birr ($0.65 USD) per injection. Being married, completing any
amount of education, having given birth, and having visited a health facility in the last 12 months (whether received family
planning information or not) were associated with statistically significantly increased odds of WTP. Having initiated sexual
activity and having 1–2 children (compared to 0 children) were associated with statistically significantly decreased odds of
WTP. We also detected two significant interactions. Among women who prefer injectable contraceptives, their odds of WTP
for injectable contraceptives vary across length of time they have used them. And among women who work for pay, their
odds of WTP for injectable contraceptives vary by whether they agree with their husband/partner about the ideal number
of children.
Conclusion: In a sector that continually struggles with funding, cost recovery for contraceptive services may offer a means
of improved financial sustainability while increasing rural access to injectable contraceptives. Results indicate there are
opportunities for cost recovery in rural Tigray, Ethiopia and highlight factors that could be leveraged to increase WTP for
injectable contraceptives.
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Introduction
The fundamental role of contraception in improving maternal
and child health is increasingly recognized by policy-makers,
researchers, and donors alike. Ahmed et al. (2012) reported that
44% of potential maternal deaths worldwide were averted by
contraceptive use in 2008. This is equivalent to 38 maternal deaths
prevented for every 100,000 reproductive age women using
contraceptive methods every year [1]. Cleland et al. (2012)
concluded that an additional 30% of maternal deaths could be
averted by fulfilling unmet need for contraception in developing
countries, particularly in sub-Saharan Africa where unmet need
for family planning, and consequently maternal mortality, is high
[2].
The numerous benefits of family planning are clear. Yet current
donor funding and government expenditures on reproductive
health services in sub-Saharan Africa are not sufficient [3], and
therefore, the issue of financial stability is a main concern in the
development and implementation of family planning programs
[4,5]. As governments and providers investigate options for cost
recovery and revenue generation, it is critical to understand factors
associated with women’s willingness to pay (WTP) for contracep-
tives.
In Ethiopia, the total fertility rate (TFR) has declined from 5.4
children per woman in 2005 to 4.8 children per woman in 2011
[6,7]. However, the 28% unmet need for family planning in rural
areas and the desired family size of 4.3 children per woman
highlight the potential for further decline in TFR by meeting
demand for contraception [6]. The growing use of modern
contraceptives and declining TFR in Ethiopia is largely attributed
to the dramatic rise in use of injectable contraceptives, which
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increased from 3% to 21% among married women between 2000
and 2011 [6,8]. This growth is not surprising given the 2005
Demographic Health Survey (DHS) finding that 72% of women
reported a preference for injectable contraceptives [7]. Injectable
contraceptives are currently used by 14% of married Ethiopian
women, with implants and pills being the second and third most
commonly-used methods at 2.3% and 1.5%, respectively [9].
However, access to injectable contraceptives is not universal and
disparities exist in the country. In 2011, 18% of women in rural
Ethiopian communities were currently using injectable contracep-
tives compared to 35% of women in urban communities despite
similar levels of preference [6]. In rural areas, the only source of
injectable contraceptives is government facilities (i.e. hospitals,
health centers, or most commonly, health posts). Women receive
injectable contraceptives for free from these facilities, but women
often live far from these facilities or arrive at facilities where the
providers are not present, have many clients whom they are
treating, or do not have any injectable contraceptives in stock.
Public health programs are increasingly charging user fees to
improve long-term sustainability in an attempt to strike a balance
between cost recovery and program reach [4]. WTP for services
among current and prospective clients influences the opportunity
for cost recovery [10,11,12]. Studies assessing WTP and the
impact of price increases on demand for health services and
commodities vary in their findings, but generally conclude that
assigning context-dependent user fees is acceptable and will result
in limited impact on demand [11,12,13,14,15,16,17]. Consensus
has not been reached on whether price increases result in non-
differential price responsiveness of different income groups
[13,14]. However, research in resource poor countries has
suggested that people living in poverty are willing to pay for
services they value, such as family planning, and perceive as high
quality [13,17,18]. One study in Egypt found that 45% of women
surveyed were willing to pay for injectable contraceptives [19].
More research is needed to build consensus around the impact of
price increases on demand and to determine the factors that
impact one’s WTP for specific services or commodities. Assessing
women’s WTP for injectable contraceptives and the related factors
influencing their WTP can provide program planners and policy-
makers with critical information.
The objective of this paper is to explore factors associated with
women’s willingness to pay and the amount women are willing to
pay for injectable contraceptives in rural Ethiopia.
Methods
Human subjects approval was obtained from the Center for
Protection of Human Subjects (CPHS) at the University of
California Berkeley (CPHS Protocol ID 2011/07/3465). We used
a multi-stage random sampling design, which provides represen-
tative data for the Central Zone of Tigray, Ethiopia. All women of
reproductive age (i.e. those between 15 and 49 years of age) in the
households randomly selected from the randomly selected kebeles
(villages) were eligible to participate in the study.
A total of sixteen trained interviewers and three supervisors
were sent to the three selected woredas (districts) in teams of five to
six interviewers and one supervisor. Data collection took a total of
15 days. Our response rate was 99%, resulting in 1490
respondents, all of whom provided verbal informed consent.
The survey data serves as the baseline for a larger evaluation of
an ongoing project testing the combination of social marketing and
community based distribution (CBD) of injectable contraceptives
in Tigray, Ethiopia. Tigray is the northernmost region of Ethiopia
and is a predominantly rural area. Conducted in October 2011,
the survey drew from the demographic, fertility, and family
planning sections of the Demographic and Health Survey (DHS)
and included additional questions regarding injectable contracep-
tives and previous payment/WTP. Among women surveyed, those
who had ever used injectable contraceptives or expressed interest
in using injectable contraceptives were asked the WTP questions.
The first question elicited a dichotomous yes/no response to
whether the woman would be willing to pay for injectable
contraceptives. The follow-up question, if she responded yes, was
open-ended and inquired how much she would be willing to pay
for injectable contraceptives in birr (the local currency). At the
time of the survey, 1 USD was equivalent to 17 Ethiopian birr. For
further details, see the Baseline Survey Report [20].
Figure 1 presents factors considered to be associated with WTP
that were available for analysis. These were categorized as
individual level, injectable contraceptive, or structural factors.
‘Individual level factors’ are those related to a woman’s social
status, economic status, or reproductive history; ‘injectable
contraceptive factors’ are those related to injectable contraceptive
use, preference, or knowledge; and ‘structural factors’ are those
external to the individual surveyed but still related to health care
utilization and knowledge, e.g. distance to the nearest facility
(estimated by respondent in hours and minutes), having visited a
facility in the last year, and exposure to family planning messages
on the television, radio, or in newspapers in the last few months.
In building our models, we began by using results from the
bivariate analysis to determine which factors to include in the
multivariate logistic regression. All covariates with p#0.05 were
included in the model. We then removed all covariates that were
not significant at the p#0.20 level in the multivariable model. For
groups of covariate categories (e.g. marriage categories, education
categories, etc.), we used the Wald test to determine whether their
contribution to the explanatory power of the model was
significant, retaining all covariate categories with p#0.20. We
kept age in the model despite it not being significant because we
hypothesized it to be a confounder of other relationships. We
tested the possibility of effect measure modification between
receiving payment for work and agreement with husband/
partner’s ideal number of children, as well as between preferred
contraceptive and length of time using injectable contraceptives; a
Wald test revealed that both sets of cross-products were significant
at the p#0.05 level.
Our final model included age, marital status, education,
payment for work, whether respondent has had sex, age at first
birth, number of living children, whether respondent agrees with
husband/partner about ideal number of children (those not in a
relationship were categorized as ‘don’t know/not with partner’),
preferred method of contraception (injectable contraceptive versus
other), total time using injectable contraceptives, health facility
visit in last 12 months (whether received family planning
information or not), and all cross-products associated with the
aforementioned interactions. Based on our multi-stage random
sampling design, we used Stata’s vce(cluster varname) option in all
logistic regressions to obtain a robust variance estimate that adjusts
for within cluster correlation [21]. Logistic regression odds ratios
(ORs) with 95% confidence intervals (CIs) and p-values were used
to assess which factors were associated with WTP; the requirement
for statistical significance was a p-value#0.05 and a 95% CI that
did not cross 1.0. Bonferroni p-value adjustments for multiple
comparison were performed to account for the 7 hypotheses tested
related to the interactions [21]. We used how much women were
willing to pay to create a WTP-based demand curve. All analyses
were conducted using Stata/IC version 11.2 [21].
Willingness to Pay for Injectable Contraceptives
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Results
Among the 1490 women surveyed, 1013 (68%) had ever used
injectable contraceptives or expressed interest in using injectable
contraceptives and thus were asked the WTP questions. Overall,
68% of these women were willing to pay for injectable
contraceptives. The open-ended WTP question revealed that
women were willing to pay, on average, 11 birr ($0.65 USD), and
that 52% of women were willing to pay 5 birr for injectable
contraceptives; 5 birr is the current cost of one injection in the
ongoing project (Figure 2).
As seen in Tables 1, 2, and 3, there were not marked differences
between the full sample and the subpopulation who were asked the
WTP questions, with the exception of ever use of injectable
contraceptives and preferred method of contraception. Among
women from the subpopulation in our analyses, 67% had ever
used injectable contraceptives and 77% said it was their preferred
method (Table 2).
Table 4 displays the bivariate results of the chi-squared tests
investigating the percent willing to pay for injectable contracep-
tives among each covariate, which were used to determine which
variables were included in the model. Among the individual level
factors, age, marital status, education, payment for work, whether
has had sex, age at first birth, and number of living children were
all significantly associated with WTP at the p#0.05 level. Among
the injectable contraceptive factors, preferred method of contra-
ception, ever-use of injectable contraceptives, average time using
injectable contraceptives, and whether knows correct coverage
time of injectable contraceptives were significantly associated with
WTP at the p#0.05 level. The structural factors that were
significant at the p#0.05 level include time to facility and health
facility visit in the last 12 months (regardless of receipt of family
planning method).
Figure 1. Factors considered to be associated with willingness to pay for injectable contraceptives that were available for analysis.
doi:10.1371/journal.pone.0064032.g001
Figure 2. Willingness to pay for injectable contraceptives among women of reproductive age who have ever used them or who are
interested in using them (N=767)*. *Approximately 3% of women were willing to pay between 50 and 200 birr; we have only labeled up to
50 birr for visual purposes X-axis: Percentage of women Y-axis: Amount Willing to Pay (in Ethiopian birr: 1 USD= 17 birr) Red line: 5 birr: cost of
injectable contraceptives in project.
doi:10.1371/journal.pone.0064032.g002
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In our final logistic regression model, several factors were found
to be significantly associated with WTP, including both sets of
cross-products (Table 5). Among the factors not associated with
the interaction terms, being married (OR=4.54, 95% CI 1.01,
20.48), all levels of education (1–4 years OR=1.71, 95% CI 1.03,
2.85; 5–9 years OR=1.92, 95% CI 1.08, 3.43; secondary school
or higher OR=3.51, 95% CI 1.64, 7.51), age at first birth (less
than 17 years OR=2.85, 95% CI 1.47, 5.53; 17–19 years
OR=3.05, 95% CI 1.30, 7.14; and greater than 19 years
OR=2.92, 95% CI 1.26, 6.78) and having visited a health facility
in the last 12 months (whether respondent received family
planning information or not, OR=3.07, 95% CI 1.58, 5.95 and
OR=3.66, 95% CI 1.44, 9.32, respectively) were associated with
statistically significantly increased odds of WTP. Having initiated
sexual activity (OR=0.17, 95% CI 0.03, 0.97), having 1–2
children (OR=0.33, 95% CI 0.18, 0.61), and having used
Table 1. Individual level factors among all women surveyed and among the WTP study subpopulation (i.e. women who had ever
used injectable contraceptives or expressed interest in using them).
Full Sample N=1490* Subpopulation N=1013
% N % N
Age
15–19 19.2 286 15.1 151
20–24 16.9 252 20.0 200
25–29 17.9 267 22.7 227
30–34 15.7 234 18.4 184
35–39 13.4 199 13.9 139
40–44 8.1 121 6.5 65
45–49 7.5 112 3.5 35
Marital status
Never married 13.6 202 8.3 84
Married/cohabiting 72.3 1077 81.0 820
Divorced/widowed 13.9 207 10.7 108
Education
No education 53.5 797 52.9 533
1–4 years 13.2 196 14.6 147
5–9 years 22.4 334 20.9 211
Secondary or greater 10.5 157 11.6 117
Works for pay 44.6 664 48.8 493
Has had intercourse 85.6 1276 92.5 922
Age at 1st birth
Has not given birth 19.7 294 14.2 141
,17 years 24.4 363 26.0 258
17–19 years 32.3 481 37.4 371
.19 years 17.8 265 18.8 186
Number of living children
0 20.7 309 14.8 149
1–2 28.7 428 32.5 327
3–4 24.3 362 26.3 265
5+ 25.6 382 26.4 266
Ideal number of children
0 14.2 211 11.8 117
1–2 7.9 118 8.3 82
3–4 35.4 528 38.1 379
5+ 39.8 593 41.9 416
Agree with husband/partner about ideal number of children
Agree 41.7 622 49.6 502
Disagree 16.9 252 18.4 186
Don’t know/not with partner 41.1 613 32.1 325
*Denominator in percent calculations include missing responses.
doi:10.1371/journal.pone.0064032.t001
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injectable contraceptives for any amount of time when they were
not the preferred method (OR=0.13, 95% CI 0.07, 0.27;
OR=0.20, 95% CI 0.11, 0.38; OR=0.23, 95% CI 0.08, 0.69
for use less than1 year, 1 to 2 years, and great than 2 years,
respectively) were associated with statistically significantly de-
creased odds of WTP.
The odds of WTP for injectable contraceptives among
women who work for pay compared to those who do not
work for pay vary by whether they agree with their husband/
partner’s ideal number of children (Table 6). Women who
disagree with their husband/partner’s ideal number of children
and who work for pay have 3.42 times the odds of being willing
to pay (95% CI 2.01, 5.62) compared to women who disagree
and do not work for pay. Women who do not know their
husband/partner’s ideal number of children or who are not
with a partner and who work for pay have 1.21 times the odds
of being willing to pay (95% CI 0.59, 2.45) compared to
women who do not know or are not with a partner and do not
work for pay. And women who agree with their husband/
partner’s ideal number of children and who work for pay have
4.07 times the odds of being willing to pay (95% CI 2.30, 7.19)
compared to women who agree and do not work for pay.
The odds of WTP for injectable contraceptives among women
who prefer injectable contraceptives compared to those who do
not prefer injectable contraceptives vary by length of time using
injectable contraceptives (Table 6). Women who have never used
injectable contraceptives and who prefer them to other methods of
contraception have 0.82 times the odds of being willing to pay
(95% CI 0.40, 1.67) compared to those who do not prefer them.
Women who have used injectable contraceptives for less than one
year and who prefer them have 2.97 times the odds of being
willing to pay (95% CI 1.83, 4.80) compared to those who do not
prefer them. Women who have used injectable contraceptives for
one to two years and who prefer them have 2.99 times the odds of
being willing to pay (95% CI 1.92, 4.66) compared to those who
do not prefer them. And women who have used injectable
contraceptives for more than two years and who prefer them have
5.10 the odds of being willing to pay (95% CI 1.90, 13.66)
compared to those who do not prefer them.
Discussion
To our knowledge this is the first study to assess factors
associated with WTP for injectable contraceptives. Results from
Table 2. Injectable contraceptive factors among all women surveyed and among the WTP study subpopulation (i.e. women who
had ever used injectable contraceptives or expressed interest in using them).
Full Sample N=1490* Subpopulation N=1013
% N % N
Injectable contraceptive is preferred method of contraception 55.3 824 76.8 730
Has ever used injectable contraceptives 46.2 688 67.0 665
Currently using injectable contraceptives 20.6 307 32.8 303
Length of time using injectable contraceptives
Never used 49.3 732 33.7 328
,1 year 14.6 218 22.1 215
1–2 years 14.7 219 21.7 211
.2 years 14.9 222 22.4 218
Knows correct coverage time of injectable contraceptives 78.1 1163 92.6 884
*Denominator in percent calculations include missing responses.
doi:10.1371/journal.pone.0064032.t002
Table 3. Structural factors among all women surveyed and among the WTP study subpopulation (i.e. women who had ever used
injectable contraceptives or expressed interest in using them).
Full Sample
N=1490* Subpopulation N=1013
% N % N
Time to facility
,30 minutes 44.6 665 46.0 462
30+ minutes 54.5 812 54.0 543
Whether visited health facility and received family planning in last 12 months
Didn’t visit 26.9 400 20.0 201
Visited and didn’t receive 12.4 185 14.1 141
Visited and received 59.5 887 65.9 661
Exposed to family planning messages on TV/magazine/newspaper in last few months 38.1 567 42.4 415
*Denominator in percent calculations include missing responses.
doi:10.1371/journal.pone.0064032.t003
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Table 4. Characteristics of the subpopulation by percent willing to pay for injectable contraceptives (N = 1013).
% willing to pay N p-value
Age
15–19 76.2 151 ,0.001
20–24 75.5 200
25–29 70.9 227
30–34 67.4 184
35–39 64.8 139
40–44 50.8 65
45–49 40.0 35
Marital status
Never married 81.0 84 0.004
Married/cohabiting 68.4 820
Divorced/widowed 58.3 108
Education
No education 61.4 533 ,0.001
1–4 years 66.0 147
5–9 years 77.7 211
Secondary or greater 87.2 117
Works for pay
No 59.8 517 ,0.001
Yes 77.3 493
Has had sex
No 85.3 75 0.001
Yes 67.3 922
Age at 1st birth
Has not given birth 80.9 141 ,0.001
,17 years 65.5 258
17–19 years 70.4 371
.19 years 67.2 186
Don’t know 25.7 35
Number of living children
0 81.2 149 ,0.001
1–2 71.3 327
3–4 65.7 265
5+ 60.2 266
Ideal number of children
0 70.1 117 0.056
1–2 65.9 82
3–4 72.6 379
5+ 63.7 416
Agree with husband/partner about ideal number of children
Agree 70.1 502 0.422
Disagree 65.1 186
Don’t know/not with partner 67.7 325
Preferred method of contraception
Not injectable contraceptives 57.5 221 ,0.001
Injectable contraceptives 73.7 729
Has ever used injectable contraceptives
No 78.4 328 ,0.001
Yes 63.9 664
Willingness to Pay for Injectable Contraceptives
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the multivariate analyses revealed multiple individual level,
injectable contraceptive, and structural factors to be associated
with a woman’s WTP for injectable contraceptives.
Among individual level factors, increasing level of education was
associated with greater WTP for injectable contraceptives. This
finding may reflect the strong associations between women’s
education and contraceptive use found in previous studies
conducted in Ethiopia [22,23]. In a study investigating WTP for
insecticide treated bed nets in southern Ethiopia, researchers also
found that education was positively associated with WTP [24].
Initiation of sexual activity was another significant individual
level factor. Survey respondents who had not yet initiated sexual
activity had a statistically significantly higher WTP for injectable
contraceptives than their sexually active counterparts. This may
indicate that they are more motivated to control their fertility even
before the initiation of sexual activity. These respondents are
younger and have a lower average desired fertility (data not
shown), and they are likely better informed. This younger
generation’s higher WTP bodes well for future cost recovery, as
the expectations of these women may differ from the previous
generations’, whose only experience with reproductive health care
in rural areas has been free government services and commodities.
Another interpretation of this finding is that WTP for contracep-
tion among non-sexually active women diminishes once they
become sexually active and the question is no longer hypothetical.
We also detected a statistically significant association between
WTP and age at first birth, another individual level factor.
Regardless of the age at first birth, women who have given birth
appear more motivated to use contraception as a means of
controlling their fertility than those who have not given birth.
We found an interaction between working for pay and
agreement with husband/partner’s ideal number of children, both
of which are individual level factors. This indicates a strong
connection between SES (or in our case a proxy for SES),
motivation for achieving desired family size, and WTP for
injectable contraceptives. This finding is in line with previous
research [4,12]. Those who receive payment for work had
significantly increased odds of WTP compared to those who do
not receive payment. The level of increased odds among those
who receive payment was dependent on whether or not they agree
with their husband/partner’s ideal number of children, with those
who agree having the highest odds. This perhaps indicates that
these women are particularly motivated to achieve their desired
family size and they feel comfortable using money to do so since
their husband/partner similarly wants to achieve that family size.
As could be expected, the injectable contraceptive factor of
preference for injectable contraceptives was associated with
increased odds of WTP for injectable contraceptives, but only if
the woman had actually used the method. Preferring injectable
contraceptives and having used this method for any amount of
time was associated with significantly increased odds of WTP
compared to those women who did not prefer it. If WTP is
considered a reflection of demand [12] and we assume that
women who prefer injectable contraceptives have a greater
demand for this method, it is logical that they would be more
motivated to use injectable contraceptives and thus more willing to
pay for them. This logic follows previous findings in the literature.
Foreit and Foreit (2003) examined WTP for contraceptive pills
and found that women whose first choice of contraception was pills
were more willing to pay for them than women whose first choice
was not pills. The authors concluded that women who preferred
pills were more motivated to use this method and therefore were
more willing to pay [4]. WTP’s relationship to demand is discussed
further below.
Table 4. Cont.
% willing to pay N p-value
Currently using injectable contraceptives
No 65.9 621 0.345
Yes 69.0 303
Length of time using injectable contraceptives
Never used 78.1 319 ,0.001
,1 year 57.6 217
1–2 years 62.9 213
.2 years 71.0 221
Knows correct coverage time of injectable contraceptives
No 80.3 71 0.046
Yes 69.0 884
Time to facility
,30 minutes 73.8 462 0.001
30+ minutes 63.9 543
Whether visited health facility and received family planning in last 12 months
Didn’t visit 52.7 201 ,0.001
Visited and didn’t receive 80.1 141
Visited and received 71.3 661
Exposed to family planning messages on TV/magazine/newspaper in last few months
No 68.6 563 0.40
Yes 71.1 415
doi:10.1371/journal.pone.0064032.t004
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Table 5. Final logistic regression model investigating willingness to pay for injectable contraceptives among women who have
ever used injectable contraceptives or who expressed interest in using injectable contraceptives when asked (N= 849).
OR p-value 95% CI
Age 0.98 0.263 0.946, 1.014
Marital status
Never married – – Reference
Married/cohabiting 4.54 0.049 1.008, 20.479
Divorced/widowed 3.08 0.147 0.673, 14.125
Education
No education – – Reference
1–4 years 1.71 0.040 1.025, 2.847
5–9 years 1.92 0.026 1.081, 3.426
Secondary or greater 3.51 0.001 1.638, 7.514
Works for pay
No – – Reference
Yes 4.07 ,0.001 2.302, 7.194
Has had sex
No – – Reference
Yes 0.17 0.047 0.029, 0.973
Age at first birth
Has not given birth – – Reference
,17 years 2.85 0.002 1.468, 5.526
17–19 years 3.05 0.010 1.300, 7.137
.19 years 2.92 0.013 1.256, 6.784
Don’t know 0.33 0.130 0.081, 1.380
Number of living children
0 – – Reference
1–2 0.33 ,0.001 0.182, 0.609
3–4 0.38 0.141 0.106, 1.374
5+ 0.41 0.141 0.125, 1.343
Agree with husband/partner about ideal number of children
Agree – – Reference
Disagree 1.26 0.455 0.684, 2.335
Don’t know/not with partner 1.85 0.205 0.714, 4.799
Preferred method of contraception
Not injectable contraceptives – – Reference
Injectable contraceptives 0.82 0.576 0.399, 1.666
Length of time using injectable contraceptives
Never used – – Reference
,1 year 0.13 ,0.001 0.065, 0.266
1–2 years 0.20 ,0.001 0.107, 0.384
.2 years 0.23 0.009 0.079, 0.694
Whether visited health facility and received family planning in last 12 months
Didn’t visit – – Reference
Visited and didn’t receive 3.66 0.007 1.437, 9.318
Visited and received 3.07 0.001 1.578, 5.952
Payment for work and agree with husband about ideal number of children cross-products
Not paid – – Reference
Paid and disagree with husband/partner 0.84 0.631 0.411, 1.714
Paid and don’t know husband’s/partner’s preference/not with partner 0.30 0.003 0.131, 0.668
Preference for injectable contraceptives and length of time have used it
Don’t prefer – – Reference
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The final model also indicates that having used injectable
contraceptives for any amount of time and not preferring this
method is associated with significantly decreased odds of WTP for
it. This interaction between two injectable contraceptive factors
seems counterintuitive, until considering that currently, the only
source of injectable contraceptives in rural areas is the govern-
ment, which provides them for free. If respondents have previously
received injectable contraceptives for free from government
facilities, their expectation will be that injectable contraceptives
are a commodity that should not require payment [12,24,25].
Existing literature indicates that expectations are integral in
shaping women’s WTP for a health commodity or service [24,25].
In addition, because it is not their preferred method, their
motivation to use it (and pay for it) is likely to be lower than those
who prefer it. As a result, women who had been using injectable
contraceptives for any amount of time but did not prefer the
method were less willing to pay for the services, demonstrating the
interplay of expectations and motivation.
Among the structural factors, women who visited a health
facility in the last 12 months (whether they received family
planning information or not) had significantly increased odds of
WTP. It is important to note that this correlation does not
necessarily indicate that a causal relationship exists, because
women who visit health facilities might also differ in other ways,
such as attitude towards contraception and education level. This is
an interesting result given that the health facilities in the surveyed
communities are public and provide free family planning services.
Qualitative findings from Malawi offer an explanation for this
finding, suggesting that even in settings where free government
services arethe norm, there are a range of factors influencing WTP
(i.e. method stock-outs, transport, or other hidden costs) [5].
Alternatively, this finding could be explained through motivation
[4], in that women who have visited a health facility in the last 12
months are more motivated to use contraception than those who
have not.
Although this analysis revealed many new and interesting
findings, they should be taken in the context of the paper’s
limitations. Unfortunately, we did not have a variable that allowed
us to determine a household’s socioeconomic status in terms of
income or assets. Much of the previous literature found this
measure of SES to be strongly associated with WTP [4,12]. We
used whether a woman is paid for her work (in cash, in kind, or
both) as a proxy for economic status, but it is admittedly
insufficient. As a result, there is likely unaccounted-for confound-
ing. Also controlling for education likely improves our proxy for
SES though. Our variable related to preferred method of
contraception (injectable versus not injectable) is from a survey
question that many respondents had difficulty answering because
there is no word for ‘preference’ in the local language. This may
have compromised the validity of responses to the question. We
included only women interested in using injectable contraceptives
in this analysis, which likely positively biased the results since
women not interested in using the method are presumably less
willing to pay for it. With regards to the WTP questions, previous
studies have found variations in results based on the elicitation
method applied. Thus our results may have been different had we
used the ‘bidding game’ method (an iterative process where a
respondent is asked whether they are willing to pay a given
amount and the follow up question asks about a higher or lower
amount depending upon the initial response) or the ‘take-it-or-
leave-it’ method (where the amount asked varies across surveys
and the question is only asked once of each respondent) [26]. In
addition, it is important to note that the WTP questions referred to
whether respondents were willing to pay for injectable contracep-
tives generally, not in the context of the improved convenience
and confidentiality provided by CBD. Previous literature has
Table 5. Cont.
OR p-value 95% CI
Prefer injectables and have used ,1 year 3.64 ,0.001 1.798, 7.365
Prefer injectables and have used 1–2 years 3.67 0.002 1.604, 8.402
Prefer injectables and have used .2 years 6.25 0.007 1.655, 23.602
doi:10.1371/journal.pone.0064032.t005
Table 6. Lincom results for odds ratios of interactions (N = 849).
OR p-value 95% CI
Odds ratios of WTP by works for pay and agreement with husband/partner about ideal number of children
Disagree: paid vs not paid 3.42 *,0.001 2.077, 5.619
Don’t know: paid vs not paid 1.21 0.605 0.594, 2.445
Agree: paid vs not paid 4.07 *,0.001 2.302, 7.194
Odds ratios of WTP by preference for injectable contraceptives and length of time have used it
Have never used: prefer vs don’t prefer 0.82 0.576 0.400, 1.666
Have used ,1 year: prefer vs don’t prefer 2.97 *,0.001 1.834, 4.803
Have used 1–2 years: prefer vs don’t prefer 2.99 *,0.001 1.924, 4.659
Have used .2 years: prefer vs don’t prefer 5.10 *0.001 1.902, 13.660
P-values and 95% CIs presented are lincom results before adjustment.
*Indicates statistical significance after Bonferroni adjustment.
doi:10.1371/journal.pone.0064032.t006
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demonstrated that consumers are more likely to pay new or
increased fees if they are paired with improved quality or less
travel time. If we consider this, the proportion of women willing to
pay for CBD of injectable contraceptives in this population is likely
even higher [5,13,18,27,28]. It is important to distinguish between
WTP and ability to pay; the two concepts are different and WTP is
not a perfect predictor of demand. As indicated by the WTP-based
demand curve, of those women who are willing to pay, the amount
for many is quite small and subsidization would be necessary in
Ethiopia. Despite these limitations, the results from our analyses
offer insight into the individual level, injectable contraceptive, and
structural factors that are associated with a woman’s WTP for
injectable contraceptives in Tigray, Ethiopia. Findings allow
government and non-profit healthcare organizations to begin
understanding ways they can improve cost recovery for injectable
contraceptive provision.
In general, it is also important to consider the broader context in
which the project and associated user fee is being implemented. In
rural Tigray, Ethiopia, the only source of injectable contraception
is government facilities, which are subject to stock outs and can be
quite far for the most rural women. Although some women may
not be able or willing to pay for injectable contraceptives from a
CBRHA in the project, the overall burden of unplanned
pregnancies would still likely be diminished because this project
only adds to existing injectable contraceptive access points; women
who cannot pay for the convenience and confidentiality of this
service can still receive free injections from existing government
facilities. Additional research should be done to determine
whether adding a user fee without increasing access increases or
decreases the overall cost to the health care system when factoring
in unplanned pregnancies.
Cost recovery for family planning services may offer a means of
improved financial sustainability in a sector that continually
struggles with funding while increasing rural access to injectable
contraceptives, the preferred method of contraception in Ethiopia.
This study demonstrates that there is substantial WTP for
injectable contraceptives and provides insight into which factors
are associated with WTP among women in Tigray, Ethiopia.
Preference for injectable contraceptives is highly associated with
WTP. Preference and motivation can likely be influenced by
information, education, and communication campaigns and
family planning counseling that highlight the importance of
contraception [29,30,31]. Educating women on modern methods
of contraception and helping them determine their preferred
method of contraception could be a means of increasing their
demand/motivation and WTP. An important consideration is the
quality of services. Researchers have repeatedly demonstrated that
improved quality of services and/or access is positively correlated
with increased WTP [5,13,18,27,28]. Government and private
sector health care systems should keep this in mind when
considering implementing or increasing user fees.
Conclusions
This study contributes to the literature examining WTP for
contraceptives and is the first to investigate factors associated with
WTP for injectable contraceptives specifically. Ethiopian women
are not alone in their preference for injectable contraceptives [32].
This method is widely preferred among women in sub-Saharan
Africa, with an estimated 9 million users constituting 43% of total
contraceptive use in the region [33]. More research is needed to
better understand what contributes to women’s WTP so that
government and private sector health care systems can work to
maximize WTP and ensure that those unwilling or unable to pay
still have access to the necessary services. Health equity is of
utmost importance, but sustainability is of growing concern and
achieving even partial cost recovery will be an increasingly
important aspect of health care delivery in the future.
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